Skip to main navigation Skip to search Skip to main content

Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series

Research output: Contribution to journal › Letter › Academic › peer-review

17 Downloads (Pure)
Original languageEnglish
Pages (from-to)586-589
Number of pages4
JournalClinical and Experimental Allergy
Volume53
Issue number5
Early online date16 Mar 2023
DOIs
Publication statusPublished - May 2023

Keywords

  • atopic dermatitis
  • autoimmunity
  • basic mechanisms
  • dermatology
  • ocular allergy

Cite this